This chapter supports SDG 3 by looking at how artificial intelligence (AI) can provide substantial improvements in all areas of healthcare from diagnostics to treatment.
Elsevier,

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Sixth Edition), Volume 1, 2020, Pages 283-297

This chapter addresses Goal 3 by discussing the genetic relationship between Alzheimer's disease and Down Syndrome.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Jo Youle, CEO of Missing People.
The SDG Impact of COVID-19 podcast series gathers expert opinion exploring the impact of COVID-19 on the Sustainable Development Goals. In this segment, we get the view of Sandra Kerr, Director of Race Equality at Business in the Community.
This book chapter advances SDGs 3 and 10 by explaining how individuals with diabetes who are of lower socioeconomic status are more likely to have poorer diabetes-related outcomes. Digital health advancements provide unique opportunities to reduce health inequities for this high-risk group.

The Atlas of Sustainable Development Goals 2020 presents interactive storytelling and data visualizations about the 17 Sustainable Development Goals.

Elsevier,

Control Theory in Biomedical Engineering Applications in Physiology and Medical Robotics 2020, Pages 205-234

This book chapter advances SDG3 Good Health and Wellbeing and SDG10 Reducing Inequalities by examining the research on wearable mechatronic devices for upper-limb amputees.
Elsevier,

Mental and Behavioral Health of Immigrants in the United States, Cultural, Environmental, and Structural Factors, 2020, Pages 157-178

This chapter addresses Goal 3 by examining the mental health of immigrants in the United States.
This book chapter addresses SDG 10 and SDG 3 by discussing the ways in which contemporary South Asian Muslim American experiences are further complicated when navigating additional marginalized identities such as gender and sexual orientation, age and generational influences, disability status, class, and national origin
Elsevier,

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Sixth Edition), Volume 1, 2020, Pages 199-207

This chapter explores a third use of neurotechnology that neither fits squarely into the category of treatment nor carries some of the moral hesitancies of pure enhancement in persons without physical or intellectual impairment. This third category, referred to as enhancement-2, is the enhancement of cognition for persons who have intellectual disabilities. This content addresses SDG 3 by giving comprehensive coverage of the neurogenetic foundation of neurological and psychiatric disease; explaining all aspects essential to the practice of neurogenetics to inform clinical diagnosis, treatment and genetic counseling.

Pages